Mondelez International, Inc. (MDLZ) Stock Analysis
Is MDLZ a good investment?
Mondelez International, Inc. (MDLZ) has a Plutrex AI rating of 38.0/100 as of November 08, 2026, indicating a Sell consensus. The stock is not classified as halal-compliant. Key strength: Free cash flow of $3.658B ($2.72/share) — exceptional for a consumer staples company — covers the $1.54/share annual dividend 1.77x, eliminates dividend cut risk, and provides $3.6B+ annually for buybacks and debt reduction without stress. Main concern: PEG of 2.87x is 17.6% above the peer average of 2.44x — MDLZ is simultaneously the slowest 5-year EPS grower in the peer group (7.25% vs. industry 10.14%, a 28.5% deficit) AND trades at a growth-adjusted premium; at current price, implied fair value of $34–$46 (using PEG 1.5–2.0x) suggests 30–50% downside; even a generous PEG of 2.0x implies fair value ~$46/share vs. $66.02 current.
Investment Summary
MDLZ at $66.02 remains materially overvalued relative to its long-term growth profile. The stock trades at a P/E of 20.81x and a PEG of 2.87 against a 5-year EPS growth rate of only 7.25% — a 17.6% PEG premium to the peer average of 2.44x, despite being the slowest long-term grower in the Food Confectioners peer group (28.5% below the industry's 10.14% 5-year growth rate). Revenue growth has actually decelerated to 2.3% from 4.1% in the prior period — a material worsening. The only partially positive development is that the P/E has contracted from 23.40x to 20.81x (–11.1%) and PEG from 3.18x to 2.87x (–9.7%), primarily because the stock's appreciation has been modest relative to earnings-per-share revisions — but this valuation improvement does not close the gap to fair value. FCF of $3.658B ($2.72/share) remains the core defensive moat, supporting the $1.54/share dividend (2.3% yield) with 1.77x coverage. News sentiment is constructive at 88.3/100 — Volume/Mix +1.8% confirms demand is real, the AI-driven Order-to-Cash initiative could structurally improve FCF, and emerging market commentary from CEO Van de Put is encouraging — but these are incremental positives, not business transformers. At $66.02, the analyst target of $72.20 implies only 9.4% upside versus meaningful downside to fair value ($46–$50 on PEG basis). The entry zone remains $54.00–$57.50 — the stock must pull back ~14–18% before risk/reward becomes adequate.
Key Strengths
- Free cash flow of $3.658B ($2.72/share) — exceptional for a consumer staples company — covers the $1.54/share annual dividend 1.77x, eliminates dividend cut risk, and provides $3.6B+ annually for buybacks and debt reduction without stress
- Volume/Mix +1.8% (per news analysis) confirms demand is real and broad-based, not purely price-driven — combined with CEO Van de Put's comments that 'snacking is clearly strong in emerging markets,' this supports revenue stability if not acceleration, and reduces the risk of an abrupt volume decline
- AI-driven Order-to-Cash transformation and cost optimization initiatives are yielding tangible results — operating margin at 20.4% is maintained despite top-line pressure, and AI-driven efficiency could improve FCF conversion over 2–3 years, partially offsetting the weak revenue growth story
Key Concerns
- PEG of 2.87x is 17.6% above the peer average of 2.44x — MDLZ is simultaneously the slowest 5-year EPS grower in the peer group (7.25% vs. industry 10.14%, a 28.5% deficit) AND trades at a growth-adjusted premium; at current price, implied fair value of $34–$46 (using PEG 1.5–2.0x) suggests 30–50% downside; even a generous PEG of 2.0x implies fair value ~$46/share vs. $66.02 current
- Revenue growth decelerated from 4.1% to 2.3% (a 43.9% deterioration) — this worsens the already weak foundation for the 9.7% next-year EPS recovery projection; EPS grew only 1.8% YoY historically, making the step-up to 9.7% increasingly fragile; without top-line support, margin improvement and buybacks can only carry earnings so far before hitting structural limits
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Profitability: Gross margin 38.1% (vs. industry 38.72%, –1.7% gap), operating margin 20.4% (vs. industry 21.41%, –4.9% gap), net margin 10.2% (vs. industry 11.29%, –9.5% gap) — MDLZ trails peers across the entire P&L. The 28-point gap between gross margin and net margin reveals heavy SG&A, D&A, and financing costs. ROE of 15.45% is 17.5% below the industry average of 18.72%, the most significant profitability gap. Health: Debt/equity of 0.64 (vs. industry 0.671, slightly better), cash of $1.628B (thin for a company this size), FCF $3.658B (exceptional — 2.25x cash on hand). Growth: Revenue growth 2.3% (decelerated from 4.1%, vs. industry 2.43% — MDLZ trails). Next-year EPS growth 9.71% (essentially flat vs. industry 9.72%). CRITICAL: 5-year EPS growth 7.25% vs. industry 10.14% — MDLZ is 28.5% below peers on the most important metric. Valuation: P/E 20.81x (vs. industry 21.69x, slight discount), but PEG 2.87x (vs. industry 2.44x, 17.6% PREMIUM) — investors pay more per unit of growth for less growth. Intrinsic value on PEG 1.5–2.0x applied to 7.25% growth implies justified P/E of 10.9–14.5x; with implied EPS ~$3.17, fair value = $34–$46/share. Even the analyst target of $72.20 represents only 9.4% upside and does not resolve the fundamental PEG overvaluation.
News Sentiment
Mondelez International is showing real signs of operational resilience, but Wall Street's enthusiasm may be getting ahead of itself. The global snack giant behind Oreo, Ritz, and Cadbury is buzzing with activity — CEO Dirk Van de Put told investors that 'snacking is clearly strong in emerging markets,' pointing to international expansion as a key growth engine for the company's future. That optimism is backed up by concrete numbers: volume and mix grew 1.8% last quarter, meaning consumers are genuinely buying more product — not just paying higher prices. On the innovation front, The Ritz Brand is heading back to the Super Bowl in 2027 with a splashy new campaign, and the iconic Oreo brand is reportedly getting a refresh that analysts say 'reinforces the buy case.' Behind the scenes, Mondelez is quietly transforming how it operates. The company is deploying AI technology to overhaul its Order-to-Cash process — the system that handles everything from customer orders to receiving payment — which could meaningfully cut costs and boost cash flow over the coming years. Meanwhile, the company raised its dividend in October, part of a pattern of consistent shareholder returns. The catch? Despite all these positives, the stock at $66 is priced at nearly triple the theoretical fair-value multiple relative to its long-term growth rate — meaning investors are paying a premium for a company that's growing slower than its peers. The business is healthy; the price is the problem.
Risk Assessment
PRIMARY RISK: Valuation — at $66.02, MDLZ offers inadequate margin of safety. The PEG of 2.87x (17.6% above peer average) with 28.5% inferior 5-year growth versus peers means the stock is priced for perfection it cannot deliver. A rerating to peer-average PEG of 2.44x on 7.25% growth implies P/E of ~17.7x and a price of ~$56 — a 15% decline from current levels without any earnings deterioration. SECONDARY RISK: Revenue deceleration — the drop from 4.1% to 2.3% revenue growth is a structural concern that undermines the 9.7% next-year EPS recovery projection. If revenue stays at 2.3% or below, EPS recovery depends entirely on margin expansion and buybacks, both of which have limits. TERTIARY RISK: Cocoa and input cost inflation — cocoa prices remain volatile; any reversal of the tailwind would pressure margins. MITIGATION: FCF of $3.658B provides a durable floor value. The $1.54/share dividend (2.3% yield) is 1.77x covered by FCF and is not at risk. For existing holders, the defensive characteristics justify holding through weakness. For new buyers, the entry zone of $54–$57.50 provides the margin of safety that $66.02 does not.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is MDLZ a halal stock?
No, Mondelez International, Inc. (MDLZ) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for MDLZ?
Mondelez International, Inc. (MDLZ) has a Plutrex AI rating of 38.0/100 with a Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is MDLZ a good investment?
According to Plutrex AI, MDLZ has a Sell rating (38.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in MDLZ?
US stocks like MDLZ can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in MDLZ?
Plutrex AI identifies the main risks for MDLZ by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.